This inventor holds 2 USPTO granted patents. Top assignee: Cytel Corporation. Active years: 1998-1999.
Company Filing History:
Years Active: 1998-1999
Title: Anna Tempczyk: Innovator in Immunoinflammatory Treatments
Introduction
Anna Tempczyk is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of immunoinflammatory disease treatments. With a total of 2 patents, her work focuses on innovative solutions that address critical health challenges.
Latest Patents
Among her latest patents is the invention titled "Cyclic CS-1 peptidomimetics, compositions and methods of using same." This invention contemplates a cyclic peptide that inhibits the binding between the VLA-4 receptor expressed on inflammatory leukocytes and the fibronectin CS-1 peptide expressed on endothelial cells involved in immunoinflammatory disease states. The patent also discloses pharmaceutical compositions containing the cyclic peptide and processes for treating immunoinflammatory conditions using this binding-inhibitory cyclic peptide.
Career Highlights
Anna Tempczyk is currently associated with Cytel Corporation, where she continues to advance her research and development efforts. Her work is pivotal in creating effective treatments for immunoinflammatory conditions, showcasing her dedication to improving patient outcomes.
Collaborations
Throughout her career, Anna has collaborated with notable colleagues, including Thomas S Arrhenius and Mariano J Elices. These partnerships have further enriched her research and contributed to the success of her innovations.
Conclusion
Anna Tempczyk stands out as a leading inventor in the field of immunoinflammatory treatments. Her innovative patents and collaborations reflect her commitment to advancing medical science and improving health care solutions.